Biohaven Pharmaceutical raises $168 million in initial public offering – MarketWatch


Yahoo Finance
Biohaven Pharmaceutical raises $168 million in initial public offering
MarketWatch
Biohaven Pharmaceutical Holding Company BHVN, +2.94% priced its initial public offering at $17 a share Thursday to raise $168.3 million. The company sold 9.9 million shares and has granted underwriters a 30-day option to buy an additional 1.485 million …
Biohaven Pharmaceutical (BHVN) IPO Opens up 18%StreetInsider.com

all 3 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd